No effect of thromboxane A2 on the attachment of tumor cell lines MDA MB 231, DU145, and U937 to the basement membrane in an in-vitro model

J Cancer Res Clin Oncol. 2001 Dec;127(12):751-4. doi: 10.1007/s004320100283.

Abstract

Purpose: A broad body of evidence indicates the involvement of P450 TxA2 (thromboxane A2 synthetase) in tumor metastasis formation. A distinct function of the enzyme in this multistep process, however, is still unknown. Therefore the effect of TxA2 (thromboxane A2) on tumor cell adhesion to the basement membrane, a key event in metastasis formation, was investigated.

Methods: A wide variety of compounds designed in our work group and identified as P450 TxA2 inhibitors were applied to several P450 TxA2-positive tumor cell lines to test their influence on tumor cell adhesion. For this purpose an in-vitro basement membrane adhesion model with the matrix gel preparation Matrigel was used.

Results: Most of the P450 TxA2 inhibitors tested had no effect on cell adhesion. Although two compounds significantly reduced tumor cell adhesion in a concentration-dependent manner, this was not related to P450 TxA2 inhibition.

Conclusion: These data indicate that TxA2 might not be involved in the attachment of tumor cell lines to the basement membrane.

MeSH terms

  • Basement Membrane / pathology
  • Cell Adhesion / drug effects
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Neoplasms / pathology*
  • Thromboxane A2 / physiology*
  • Thromboxane-A Synthase / antagonists & inhibitors
  • Thromboxane-A Synthase / physiology
  • Tumor Cells, Cultured
  • U937 Cells

Substances

  • Enzyme Inhibitors
  • Thromboxane A2
  • Thromboxane-A Synthase